Aqr Capital Management LLC Selecta Biosciences Inc Transaction History

Aqr Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.67 - $1.4 $490,108 - $1.02 Million	731,505 Added 131.46%	1,287,949 $1.69 Million
Q1 2022 May 16, 2022	BUY	$1.23 - $3.31 $30,772 - $82,809	25,018 Added 4.71%	556,444 $684,000
Q4 2021 Feb 14, 2022	BUY	$2.89 - $4.43 $396,112 - $607,189	137,063 Added 34.76%	531,426 $1.73 Million
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.62 $180,700 - $248,463	53,780 Added 15.79%	394,363 $1.64 Million
Q2 2021 Aug 16, 2021	SELL	$2.82 - $5.01 $213,259 - $378,876	-75,624 Reduced 18.17%	340,583 $1.42 Million
Q1 2021 May 17, 2021	BUY	$2.92 - $5.07 $24,989 - $43,389	8,558 Added 2.1%	416,207 $1.88 Million
Q4 2020 Feb 16, 2021	BUY	$1.64 - $3.42 $177,121 - $369,363	108,001 Added 36.04%	407,649 $1.24 Million
Q3 2020 Nov 16, 2020	BUY	$2.18 - $2.84 $653,232 - $851,000	299,648 New	299,648 $743,000
Q2 2019 Aug 14, 2019	SELL	$1.79 - $3.05 $380,845 - $648,927	-212,763 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$1.47 - $3.06 $312,761 - $651,054	212,763 New	212,763 $504,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.